日本生物材料市場報告（按類型（天然生物材料、金屬生物材料、陶瓷生物材料、聚合物生物材料）、應用（神經科、心臟科、骨科、傷口護理、牙科、整形外科及其他）和地區分類，2026-2034）

Japan Biomaterials Market Report by Type (Natural Biomaterial, Metallic Biomaterial, Ceramic Biomaterial, Polymeric Biomaterial), Application (Neurology, Cardiology, Orthopedics, Wound Care, Dental, Plastic Surgery, and Others), and Region 2026-2034

出版日期: 2026年01月01日 | 出版商:

IMARC | 英文 121 Pages | 商品交期: 5-7個工作天內

價格

簡介目錄

2025年，日本生物材料市場規模達83.53億美元。展望未來， IMARC Group預計到2034年，該市場規模將達到220.702億美元，2026年至2034年期間的複合年成長率（CAGR）為11.40%。心血管疾病、糖尿病和骨科疾病等慢性病病例的增加，以及對生物材料醫療器材和療法的需求不斷成長，是推動市場成長的主要因素。

本報告解答的關鍵問題：

日本生物材料市場目前表現如何？未來幾年又將如何發展？
新冠疫情對日本生物材料市場產生了哪些影響？
日本生物材料市場按類型分類的組成是怎樣的？
日本生物材料市場依應用領域分類的組成是怎樣的？
日本生物材料市場價值鏈的各個階段有哪些？
日本生物材料領域的主要促進因素和挑戰是什麼？
日本生物材料市場的結構是怎麼樣的？主要參與者有哪些？
日本生物材料市場的競爭程度如何？

Japan biomaterials market size reached USD 8,353.0 Million in 2025. Looking forward, IMARC Group expects the market to reach USD 22,070.2 Million by 2034, exhibiting a growth rate (CAGR) of 11.40% during 2026-2034. The rising cases of chronic ailments, such as cardiovascular diseases, diabetes, and orthopedic disorders, and the increasing need for biomaterial-based medical devices and therapies, are primarily driving the market.

Biomaterials are substances designed and engineered to interact with biological systems, often for medical or therapeutic purposes. These materials are used in a variety of applications, from artificial organs and tissue engineering to drug delivery systems and medical implants. Biomaterials can be natural, synthetic, or a combination of both, and they are carefully selected based on their compatibility with the human body. Natural biomaterials, such as collagen and silk, are derived from biological sources and are known for their biocompatibility. Synthetic biomaterials, like polymers and ceramics, are tailored for specific properties like strength and durability. The choice of biomaterial depends on the intended function and location within the body. Biomaterials play a crucial role in modern medicine, enabling advancements in treatments and procedures. They can promote tissue regeneration, provide structural support, and serve as carriers for therapeutic agents. However, ensuring their safety and effectiveness is paramount, as they must not elicit harmful immune responses or adverse reactions when introduced into the body. Researchers continually innovate in the field of biomaterials to enhance medical treatments and improve patient outcomes.

Japan Biomaterials Market Trends:

The biomaterials market in Japan is witnessing robust growth, primarily driven by several interconnected factors. Firstly, the increasing cases of chronic diseases such as cardiovascular disorders and orthopedic ailments have propelled the demand for biomaterials in the medical field. Furthermore, an aging regional population is contributing to this trend, as older individuals require more medical interventions that often involve biomaterials. Secondly, technological advancements have significantly enhanced the versatility and effectiveness of biomaterials. This is exemplified by the development of bioactive ceramics, biodegradable polymers, and tissue engineering techniques, which have expanded the scope of biomaterial applications. Thirdly, the growing awareness of the environmental impact of traditional materials has led to a surge in demand for sustainable biomaterials. As consumers become more eco-conscious, biomaterials made from renewable sources, like plant-based polymers, gain traction in various industries, including packaging and automotive. Lastly, numerous government initiatives and regulations that are promoting the use of biomaterials for medical and industrial purposes, are expected to drive the biomaterials market in Japan during the forecast period.

Japan Biomaterials Market Segmentation:

Type Insights:

Natural Biomaterial
Metallic Biomaterial
Ceramic Biomaterial
Polymeric Biomaterial

Application Insights:

Neurology
Cardiology
Orthopedics
Wound Care
Dental
Plastic Surgery
Others
A detailed breakup and analysis of the market based on the application have also been provided in the report. This includes neurology, cardiology, orthopedics, wound care, dental, plastic surgery, and others.

Regional Insights:

Kanto Region
Kansai/Kinki Region
Central/ Chubu Region
Kyushu-Okinawa Region
Tohoku Region
Chugoku Region
Hokkaido Region
Shikoku Region
The report has also provided a comprehensive analysis of all the major regional markets, which include Kanto Region, Kansai/Kinki Region, Central/ Chubu Region, Kyushu-Okinawa Region, Tohoku Region, Chugoku Region, Hokkaido Region, and Shikoku Region.

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape in the market. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.

Key Questions Answered in This Report:

How has the Japan biomaterials market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the Japan biomaterials market?
What is the breakup of the Japan biomaterials market on the basis of type?
What is the breakup of the Japan biomaterials market on the basis of application?
What are the various stages in the value chain of the Japan biomaterials market?
What are the key driving factors and challenges in the Japan biomaterials?
What is the structure of the Japan biomaterials market and who are the key players?
What is the degree of competition in the Japan biomaterials market?

1 Preface

2 Scope and Methodology

2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Japan Biomaterials Market - Introduction

4.1 Overview
4.2 Market Dynamics
4.3 Industry Trends
4.4 Competitive Intelligence

5 Japan Biomaterials Market Landscape

5.1 Historical and Current Market Trends (2020-2025)
5.2 Market Forecast (2026-2034)

6 Japan Biomaterials Market - Breakup by Type

6.1 Natural Biomaterial
- 6.1.1 Overview
- 6.1.2 Historical and Current Market Trends (2020-2025)
- 6.1.3 Market Forecast (2026-2034)
6.2 Metallic Biomaterial
- 6.2.1 Overview
- 6.2.2 Historical and Current Market Trends (2020-2025)
- 6.2.3 Market Forecast (2026-2034)
6.3 Ceramic Biomaterial
- 6.3.1 Overview
- 6.3.2 Historical and Current Market Trends (2020-2025)
- 6.3.3 Market Forecast (2026-2034)
6.4 Polymeric Biomaterial
- 6.4.1 Overview
- 6.4.2 Historical and Current Market Trends (2020-2025)
- 6.4.3 Market Forecast (2026-2034)

7 Japan Biomaterials Market - Breakup by Application

7.1 Neurology
- 7.1.1 Overview
- 7.1.2 Historical and Current Market Trends (2020-2025)
- 7.1.3 Market Forecast (2026-2034)
7.2 Cardiology
- 7.2.1 Overview
- 7.2.2 Historical and Current Market Trends (2020-2025)
- 7.2.3 Market Forecast (2026-2034)
7.3 Orthopedics
- 7.3.1 Overview
- 7.3.2 Historical and Current Market Trends (2020-2025)
- 7.3.3 Market Forecast (2026-2034)
7.4 Wound Care
- 7.4.1 Overview
- 7.4.2 Historical and Current Market Trends (2020-2025)
- 7.4.3 Market Forecast (2026-2034)
7.5 Dental
- 7.5.1 Overview
- 7.5.2 Historical and Current Market Trends (2020-2025)
- 7.5.3 Market Forecast (2026-2034)
7.6 Plastic Surgery
- 7.6.1 Overview
- 7.6.2 Historical and Current Market Trends (2020-2025)
- 7.6.3 Market Forecast (2026-2034)
7.7 Others
- 7.7.1 Historical and Current Market Trends (2020-2025)
- 7.7.2 Market Forecast (2026-2034)

8 Japan Biomaterials Market - Breakup by Region

8.1 Kanto Region
- 8.1.1 Overview
- 8.1.2 Historical and Current Market Trends (2020-2025)
- 8.1.3 Market Breakup by Type
- 8.1.4 Market Breakup by Application
- 8.1.5 Key Players
- 8.1.6 Market Forecast (2026-2034)
8.2 Kansai/Kinki Region
- 8.2.1 Overview
- 8.2.2 Historical and Current Market Trends (2020-2025)
- 8.2.3 Market Breakup by Type
- 8.2.4 Market Breakup by Application
- 8.2.5 Key Players
- 8.2.6 Market Forecast (2026-2034)
8.3 Central/ Chubu Region
- 8.3.1 Overview
- 8.3.2 Historical and Current Market Trends (2020-2025)
- 8.3.3 Market Breakup by Type
- 8.3.4 Market Breakup by Application
- 8.3.5 Key Players
- 8.3.6 Market Forecast (2026-2034)
8.4 Kyushu-Okinawa Region
- 8.4.1 Overview
- 8.4.2 Historical and Current Market Trends (2020-2025)
- 8.4.3 Market Breakup by Type
- 8.4.4 Market Breakup by Application
- 8.4.5 Key Players
- 8.4.6 Market Forecast (2026-2034)
8.5 Tohoku Region
- 8.5.1 Overview
- 8.5.2 Historical and Current Market Trends (2020-2025)
- 8.5.3 Market Breakup by Type
- 8.5.4 Market Breakup by Application
- 8.5.5 Key Players
- 8.5.6 Market Forecast (2026-2034)
8.6 Chugoku Region
- 8.6.1 Overview
- 8.6.2 Historical and Current Market Trends (2020-2025)
- 8.6.3 Market Breakup by Type
- 8.6.4 Market Breakup by Application
- 8.6.5 Key Players
- 8.6.6 Market Forecast (2026-2034)
8.7 Hokkaido Region
- 8.7.1 Overview
- 8.7.2 Historical and Current Market Trends (2020-2025)
- 8.7.3 Market Breakup by Type
- 8.7.4 Market Breakup by Application
- 8.7.5 Key Players
- 8.7.6 Market Forecast (2026-2034)
8.8 Shikoku Region
- 8.8.1 Overview
- 8.8.2 Historical and Current Market Trends (2020-2025)
- 8.8.3 Market Breakup by Type
- 8.8.4 Market Breakup by Application
- 8.8.5 Key Players
- 8.8.6 Market Forecast (2026-2034)

9 Japan Biomaterials Market - Competitive Landscape

9.1 Overview
9.2 Market Structure
9.3 Market Player Positioning
9.4 Top Winning Strategies
9.5 Competitive Dashboard
9.6 Company Evaluation Quadrant

10 Profiles of Key Players

10.1 Company A
- 10.1.1 Business Overview
- 10.1.2 Product Portfolio
- 10.1.3 Business Strategies
- 10.1.4 SWOT Analysis
- 10.1.5 Major News and Events
10.2 Company B
- 10.2.1 Business Overview
- 10.2.2 Product Portfolio
- 10.2.3 Business Strategies
- 10.2.4 SWOT Analysis
- 10.2.5 Major News and Events
10.3 Company C
- 10.3.1 Business Overview
- 10.3.2 Product Portfolio
- 10.3.3 Business Strategies
- 10.3.4 SWOT Analysis
- 10.3.5 Major News and Events
10.4 Company D
- 10.4.1 Business Overview
- 10.4.2 Product Portfolio
- 10.4.3 Business Strategies
- 10.4.4 SWOT Analysis
- 10.4.5 Major News and Events
10.5 Company E
- 10.5.1 Business Overview
- 10.5.2 Product Portfolio
- 10.5.3 Business Strategies
- 10.5.4 SWOT Analysis
- 10.5.5 Major News and Events

11 Japan Biomaterials Market - Industry Analysis

11.1 Drivers, Restraints, and Opportunities
- 11.1.1 Overview
- 11.1.2 Drivers
- 11.1.3 Restraints
- 11.1.4 Opportunities
11.2 Porters Five Forces Analysis
- 11.2.1 Overview
- 11.2.2 Bargaining Power of Buyers
- 11.2.3 Bargaining Power of Suppliers
- 11.2.4 Degree of Competition
- 11.2.5 Threat of New Entrants
- 11.2.6 Threat of Substitutes
11.3 Value Chain Analysis